116 related articles for article (PubMed ID: 38128067)
1. Should the Breast Cancer Staging System be Revised?
Sanli AN; Tekcan Sanli DE; Aydogan F; Altundag MK
Am Surg; 2024 May; 90(5):1066-1073. PubMed ID: 38128067
[TBL] [Abstract][Full Text] [Related]
2. Clinical implication of subcategorizing T2 category into T2a and T2b in TNM staging of breast cancer.
Jung J; Suh YJ; Ko BK; Lee ES; Kim EK; Paik NS; Byun KD; Hwang KT
Cancer Med; 2018 Nov; 7(11):5514-5524. PubMed ID: 30311421
[TBL] [Abstract][Full Text] [Related]
3. Survival Comparisons between Breast Conservation Surgery and Mastectomy Followed by Postoperative Radiotherapy in Stage I-III Breast Cancer Patients: Analysis of the Surveillance, Epidemiology, and End Results (Seer) Program Database.
Xiang W; Wu C; Wu H; Fang S; Liu N; Yu H
Curr Oncol; 2022 Aug; 29(8):5731-5747. PubMed ID: 36005190
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pathological characteristics, and recurrence rates of stage T1c versus T2a or T2b prostate cancer.
Ramos CG; Carvalhal GF; Smith DS; Mager DE; Catalona WJ
J Urol; 1999 May; 161(5):1525-9. PubMed ID: 10210388
[TBL] [Abstract][Full Text] [Related]
5. [The 1992 TNM classification of T2 prostate cancer predicts pathologic stage and prognosis better than the revised 1997 classification].
Koh H; Maru N; Muramoto M; Wheeler TM; Scardino PT; Ohori M
Nihon Hinyokika Gakkai Zasshi; 2002 Jul; 93(5):595-601. PubMed ID: 12174634
[TBL] [Abstract][Full Text] [Related]
6. Discussion on the rationality of FIGO 2018 stage IIIC for cervical cancer with oncological outcomes: a cohort study.
Li Z; Duan H; Guo J; Yang Y; Wang W; Hao M; Li W; Li P; Bin X; Lang J; Liu P; Chen C
Ann Transl Med; 2022 Jan; 10(2):122. PubMed ID: 35282078
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and meta-analysis of survival outcomes in T2a and T2b gallbladder cancers.
Alrawashdeh W; Kamarajah SK; Gujjuri RR; Cambridge WA; Shrikhande SV; Wei AC; Abu Hilal M; White SA; Pandanaboyana S
HPB (Oxford); 2022 Jun; 24(6):789-796. PubMed ID: 35042673
[TBL] [Abstract][Full Text] [Related]
8. Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors.
Ye Y; Li Z; Kang S; Yang Y; Ling B; Wang L; Yao J; Li P; Wang X; Gong S; Fan H; Kong Y; Cao Y; Lang J; Liu P; Chen C
BMC Cancer; 2023 May; 23(1):421. PubMed ID: 37161372
[TBL] [Abstract][Full Text] [Related]
9. A pooled exploratory analysis of the effect of tumor size and KRAS mutations on survival benefit from adjuvant platinum-based chemotherapy in node-negative non-small cell lung cancer.
Cuffe S; Bourredjem A; Graziano S; Pignon JP; Domerg C; Ezzalfani M; Seymour L; Strevel E; Burkes R; Capelletti M; Jänne PA; Tsao MS; Shepherd FA
J Thorac Oncol; 2012 Jun; 7(6):963-72. PubMed ID: 22588152
[TBL] [Abstract][Full Text] [Related]
10. Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection.
Zhao J; Zhang W; Zhang J; Zhang Y; Ma WJ; Liu SY; Li FY; Song B
BMC Cancer; 2020 Sep; 20(1):849. PubMed ID: 32883228
[TBL] [Abstract][Full Text] [Related]
11. Appropriate surgical modalities for stages T2a and T2b in the eighth TNM classification of lung cancer.
Bie F; Qu X; Yang X; Pang Z; Yang Y; Liu S; Dong W; Du J
Sci Rep; 2017 Oct; 7(1):13050. PubMed ID: 29026165
[TBL] [Abstract][Full Text] [Related]
12. Size of Stage IIIA primary lung cancers and survival: a surveillance, epidemiology and end results database analysis.
Maximus S; Nguyen DV; Mu Y; Calhoun RF; Cooke DT
Am Surg; 2012 Nov; 78(11):1232-7. PubMed ID: 23089441
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of risk factors of axillary lymph node metastasis and prognosis in T1 breast cancer: a large-scale retrospective study based on the SEER database].
Wang WY; Meng XZ; Li N; Zeng HM; Liu JX; Feng KX; Wang PL; Wang X
Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(27):2152-2158. PubMed ID: 34275251
[No Abstract] [Full Text] [Related]
14. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.
Chen HL; Zhou MQ; Tian W; Meng KX; He HF
PLoS One; 2016; 11(10):e0165409. PubMed ID: 27798652
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive study of clinical features, prognostic factors, and survival in patients with pancreatic solid pseudopapillary neoplasms based on the 2019 WHO classification.
Luo W; Chen H; Wang J; Qiu J; Zhang T
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12393-12404. PubMed ID: 37438539
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a beneficial effect of adjuvant chemotherapy in patients with stage I triple-negative breast cancer: a population-based study using the SEER 18 database.
Du ZL; Wang Y; Wang DY; Zhang L; Bian ZM; Deng Y; Xu CS; Lin DC; Xie L; Jia Y; Gao JD; Zhang BL
Breast Cancer Res Treat; 2020 Sep; 183(2):429-438. PubMed ID: 32647940
[TBL] [Abstract][Full Text] [Related]
17. The role of adjuvant chemotherapy in stage I-III male breast cancer: a SEER-based analysis.
Li WP; Gao HF; Ji F; Zhu T; Cheng MY; Yang M; Yang CQ; Zhang LL; Li JQ; Zhang JS; Wang K
Ther Adv Med Oncol; 2020; 12():1758835920958358. PubMed ID: 33014148
[TBL] [Abstract][Full Text] [Related]
18. Verification of the newly proposed T category (seventh edition of the tumor, node, and metastasis classification) from a clinicopathological viewpoint in non-small cell lung cancer-special reference to tumor size.
Yano T; Morodomi Y; Ito K; Yoshida T; Haro A; Shoji F; Koga T; Maehara Y
J Thorac Oncol; 2010 Jan; 5(1):45-8. PubMed ID: 19884855
[TBL] [Abstract][Full Text] [Related]
19. A retrospective comparative cohort study of SEER database analysis of the prognostic value of breast-conserving surgery and mastectomy in patients with multifocal multicenter breast cancer.
Yu M; Xia L; Cao B; Wang M; Liu S; Liu S; Mou E; Li H; Wang H
Gland Surg; 2023 Feb; 12(2):165-182. PubMed ID: 36915807
[TBL] [Abstract][Full Text] [Related]
20. Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based Study.
Chen W; Huang Y; Lewis GD; Szeja SS; Hatch SS; Farach A; Miltenburg D; Butler EB; Chang JC; Teh BS
Clin Breast Cancer; 2018 Feb; 18(1):e97-e105. PubMed ID: 28888581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
